Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magnesium citrate + polyethylene glycol is a combination osmotic laxative regimen used primarily for bowel cleansing prior to diagnostic procedures such as colonoscopy or colon capsule endoscopy. Polyethylene glycol (PEG) is a high-molecular-weight, non-absorbable polymer that acts as an osmotic agent, retaining water within the intestinal lumen to increase stool volume and soften fecal matter. Magnesium citrate is a saline laxative that further increases osmotic pressure, drawing water into the intestines and stimulating peristalsis. This combination is often employed to achieve thorough colonic lavage while reducing the total volume of PEG solution required, thereby improving patient compliance and tolerability compared to high-volume PEG-only regimens. It has been studied for optimizing bowel preparation in specific populations, including patients with ulcerative colitis and those with spinal cord injuries.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium citrate + polyethylene glycol.